tiprankstipranks
Advertisement
Advertisement

IMNN Stock Latest News

Imunon Earnings Call: Strong Data, Tight Cash Runway
Company AnnouncementsImunon Earnings Call: Strong Data, Tight Cash Runway
11d ago
IMNN
Imunon announces final clinical data from OVATION 2 clinical trial
PremiumThe Fly
Imunon announces final clinical data from OVATION 2 clinical trial
21d ago
IMNN
IMNN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
IMNN Earnings this Week: How Will it Perform?
22d ago
IMNN
Imunon Expands At-The-Market Equity Offering Capacity
PremiumCompany Announcements
Imunon Expands At-The-Market Equity Offering Capacity
23d ago
8K
IMNN
Imunon announces orderly retirement of chief scientific officer
PremiumCompany Announcements
Imunon announces orderly retirement of chief scientific officer
2M ago
8K
IMNN
Imunon announces reorganization to eliminate headcount for Phase 3 trial
PremiumThe FlyImunon announces reorganization to eliminate headcount for Phase 3 trial
2M ago
IMNN
Imunon Announces CFO Transition and Reappointment of Jeffrey Church
Premium
Company Announcements
Imunon Announces CFO Transition and Reappointment of Jeffrey Church
3M ago
8K
IMNN
Imunon Announces $7 Million Registered Direct Offering
Premium
Company Announcements
Imunon Announces $7 Million Registered Direct Offering
3M ago
8K
IMNN
Imunon prices 1.94M shares at $3.61 in registered direct offering
PremiumThe Fly
Imunon prices 1.94M shares at $3.61 in registered direct offering
4M ago
IMNN
Imunon CEO says ‘poised for key milestones’ as company enters 2026
PremiumThe Fly
Imunon CEO says ‘poised for key milestones’ as company enters 2026
4M ago
IMNN
Imunon, Inc. Faces Market Volatility: The Impact of Short Selling on Stock Prices
PremiumCompany Announcements
Imunon, Inc. Faces Market Volatility: The Impact of Short Selling on Stock Prices
5M ago
IMNN
IMUNON, Inc. Reports Q3 2025 Results and Progress
PremiumCompany Announcements
IMUNON, Inc. Reports Q3 2025 Results and Progress
5M ago
IMNN
Imunon, Inc. Earnings Call Highlights Progress and Challenges
PremiumCompany AnnouncementsImunon, Inc. Earnings Call Highlights Progress and Challenges
5M ago
IMNN
Imunon reports Q3 EPS ($1.16) vs ($3.76) last year
Premium
The Fly
Imunon reports Q3 EPS ($1.16) vs ($3.76) last year
5M ago
IMNN
Imunon expects cash to fund operations into Q1 of 2026
Premium
The Fly
Imunon expects cash to fund operations into Q1 of 2026
5M ago
IMNN
Is IMNN a Buy, Before Earnings?
PremiumPre-Earnings
Is IMNN a Buy, Before Earnings?
5M ago
IMNN
Imunon showcases progress on IMNN-001 at R&D Day
PremiumThe Fly
Imunon showcases progress on IMNN-001 at R&D Day
5M ago
IMNN
Imunon to present Phase 3 OVATION 3 study of IMNN-001
PremiumThe Fly
Imunon to present Phase 3 OVATION 3 study of IMNN-001
6M ago
IMNN
Imunon, Inc. Advances Phase 3 Trial for Innovative Cancer Treatment
PremiumCompany Announcements
Imunon, Inc. Advances Phase 3 Trial for Innovative Cancer Treatment
6M ago
IMNN
Imunon, Inc. Advances Phase II Study on IMNN-001 for Ovarian Cancer
PremiumCompany AnnouncementsImunon, Inc. Advances Phase II Study on IMNN-001 for Ovarian Cancer
6M ago
IMNN
Imunon to present Phase 3 OVATION trial of IMNN-001
Premium
The Fly
Imunon to present Phase 3 OVATION trial of IMNN-001
6M ago
IMNN
Imunon: OVATION 2 study results reinforce IMNN-001 efficacy benefits
Premium
The Fly
Imunon: OVATION 2 study results reinforce IMNN-001 efficacy benefits
7M ago
IMNN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >